Effectiveness of Modified Diaphragmatic Training for Gastroesophageal Reflux Disease Post Covid-19
GERD, Post COVID-19 Condition, Diaphragm Issues
About this trial
This is an interventional treatment trial for GERD focused on measuring Diaphragmatic Training, GERD-Q Score, Diaphragmatic Excursion, Maximal Inspiratory Pressure, Lung Function, GERD After COVID-19
Eligibility Criteria
Inclusion Criteria: Male and female after recover from moderate COVID-19. Six month post COVID-19 Age 18 to 60 years old GERD-Q Score more than 7 Agree to participate in the study Well understanding of the study procedure. Exclusion Criteria: History of ventilator used while COVID History of uncontrolled cardiac problems and chronic pulmonary Pregnancy or lactation History of surgery in the abdomen of the thoracic area Severe scoliosis or Kyphotic HIV/ AIDS, Autoimmune Prolonged use of dyslipidemia drug more than 1 year Prolonged use of prokinetic gastric drug more than 4 weeks
Sites / Locations
- Faculty of Medicine, Universitas Indonesia
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Interventional Group
Control Group
Baseline measurement will be done in the rehabilitation center. Participants will receive modified diaphragmatic training using modified diaphragmatic training with increased load every week for strength training (60% from inspiratory muscle strength). Weekly follow-up will be taken to reassure the respiratory muscle strength. Prescription for intervention will be determined based on the result of baseline measurement. After 4 weeks post-intervention measurement will be taken.
Baseline measurement will be done in the rehabilitation center. Participants will receive standard diaphragmatic training using a sitting position. Weekly follow-ups will be taken to remeasure the respiratory muscle strength and training procedure. After 4 weeks post-intervention measurements will be taken.